Summary

Europe Stroke Management Market is valued at approximately USD 10.88 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 6.98% over the forecast period 2024-2032. Stroke care involves providing comprehensive treatment to individuals who have experienced a stroke, a sudden interruption in blood flow to the brain. A blockage in a blood vessel can result in an ischemic stroke, while a blood vessel bursting can lead to a hemorrhagic stroke. Administering different medical interventions and therapies is necessary to manage a stroke effectively, prevent further brain damage, minimize disability, and facilitate the recovery process. Treatment plans consist of emergency interventions such as thrombolytics or clot removal, rehabilitation therapies such as physical therapy, speech therapy, and occupational therapy, medications for preventing future strokes, and lifestyle modifications for reducing risk factors such as high blood pressure, diabetes, and smoking. Managing strokes aims to improve outcomes and the overall quality of life for stroke survivors. Significant advancements in the Europe Stroke Management Market involve the increase in telemedicine and digital health options for remote stroke treatment, the use of artificial intelligence and machine learning for early identification and tailored therapy, and the focus on multidisciplinary stroke teams and comprehensive centres to improve coordination and intervention effectiveness. These advancements demonstrate creativity, efficiency, and improved patient outcomes in stroke treatment.

Various crucial factors fuel the growth of the Europe Stroke Management Market. Advancements in medical technology, such as telemedicine and digital health solutions, are crucial for providing remote assessment and treatment for stroke patients, ultimately improving their access to specialized care. Additionally, the improved incorporation of artificial intelligence and machine learning algorithms in stroke care leads to enhanced early detection and personalized treatment strategies, ultimately leading to better patient outcomes. Emphasizing stroke teams with a variety of skills and comprehensive stroke centres promotes cooperation among medical professionals, resulting in quick interventions and better outcomes for patients. However, there are also certain constraints that the market faces. The challenges revolve around the rules for telemedicine and digital health innovations and concerns regarding data privacy and security in AI-driven healthcare technologies. Moreover, the costs associated with incorporating cutting-edge stroke management technologies and the need for skilled professionals pose challenges to the widespread adoption and effective utilization of these innovations in the Europe Stroke Management Market.

The key countries considered for the Europe Stroke Management market study include the UK, Germany, France, Italy, Spain, and the Rest of Europe. Germany is a dominating region in the Europe Stroke Management Market. Renowned for its advanced healthcare infrastructure and innovative approaches, Germany leads in stroke management technologies and services. The country's healthcare system prioritizes research, development, and implementation of cutting-edge treatments for stroke patients. Collaborations between medical institutions, technology companies, and research centres further enhance Germany's position as a leader in stroke management. This dominance is reflected in the adoption of advanced imaging techniques, minimally invasive procedures, and personalized treatment plans tailored to individual patient needs. Therefore, Germany is recognized as a central point in stroke treatment across Europe. The market in the UK, on the other hand, is expected to develop at the fastest rate over the forecast period.

Major market player included in this report are:
Siemens Healthineers AG
Koninklijke Philips N.V.
Brainomix Limited
C.H. Boehringer Sohn AG & Co. KG
Elekta AB
Medtronic plc
Getinge AB
Bristol-Myers Squibb GmbH & Co.
Company 9
Company 10
The detailed segments and sub-segment of the market are explained below:

By Type
Diagnostics
Therapeutics
Software

By Application
Ischemic Stroke
Haemorrhagic Stroke
By Region:
Europe
UK
Germany
France
Spain
Italy
ROE

Years considered for the study are as follows:
Historical year – 2022
Base year – 2023
Forecast period – 2024 to 2032

Key Takeaways:
Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and Country level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market

ページTOPに戻る

Table of Contents

Chapter 1. Europe Stroke Management Market Definition and Research Assumptions
1.1. Research Objective
1.2. Market Definition
1.3. Research Assumptions
1.3.1. Inclusion & Exclusion
1.3.2. Limitations
1.3.3. Supply Side Analysis
1.3.3.1. Availability
1.3.3.2. Infrastructure
1.3.3.3. Regulatory Environment
1.3.3.4. Market Competition
1.3.3.5. Economic Viability (Consumer’s Perspective)
1.3.4. Demand Side Analysis
1.3.4.1. Regulatory frameworks
1.3.4.2. Technological Advancements
1.3.4.3. Environmental Considerations
1.3.4.4. Consumer Awareness & Acceptance
1.4. Estimation Methodology
1.5. Years Considered for the Study
1.6. Currency Conversion Rates

Chapter 2. Executive Summary
2.1. Europe Stroke Management Market Size & Forecast (2022- 2032)
2.2. Regional Summary
2.3. Segmental Summary
2.3.1. By Type
2.3.2. By Application
2.4. Key Trends
2.5. Recession Impact
2.6. Analyst Recommendation & Conclusion
Chapter 3. Europe Stroke Management Market Dynamics
3.1. Market Drivers
3.2. Market Challenges
3.3. Market Opportunities
Chapter 4. Europe Stroke Management Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Europe Stroke Management Market Size & Forecasts by Type 2022-2032
5.1. Diagnostics
5.2. Therapeutics
5.3. Software
Chapter 6. Europe Stroke Management Market Size & Forecasts by Application 2022-2032
6.1. Ischemic Stroke
6.2. Haemorrhagic Stroke
Chapter 7. Europe Stroke Management Market Size & Forecasts by Country 2022-2032
7.1. U.K. Stroke Management Market
7.1.1. Type breakdown size & forecasts, 2022-2032
7.1.2. Application breakdown size & forecasts, 2022-2032
7.2. Germany Stroke Management Market
7.3. France Stroke Management Market
7.4. Spain Stroke Management Market
7.5. Italy Stroke Management Market
7.6. Rest of Europe Stroke Management Market
Chapter 8. Competitive Intelligence
8.1. Key Company SWOT Analysis
8.1.1. Company 1
8.1.2. Company 2
8.1.3. Company 3
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. Siemens Healthineers AG
8.3.1.1. Key Information
8.3.1.2. Overview
8.3.1.3. Financial (Subject to Data Availability)
8.3.1.4. Product Summary
8.3.1.5. Market Strategies
8.3.2. Koninklijke Philips N.V.
8.3.3. Brainomix Limited
8.3.4. C.H. Boehringer Sohn AG & Co. KG
8.3.5. Elekta AB
8.3.6. Medtronic plc
8.3.7. Getinge AB
8.3.8. Bristol-Myers Squibb GmbH & Co.
8.3.9. Company 9
8.3.10. Company 10
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes